glp 1 journey meaning Timeline of GLP-1 discovery and clinical development. (a) Key events in GLP-1 Medications: Weight Loss &

Some act quickly, while others take longer to produce an effect

Ariyoshi, T., et al

Clinical trial data and FDA labeling information indicate that gastrointestinal effects are dose-dependent and typically most pronounced during initial treatment or dose escalation

Conclusion Diarrhea on a GLP1 medication is common, especially during the first weeks and after dose increases

Mounjaro and Zepbound contain tirzepatide

In Mar26, Bayer received EC approval for Kerendia (finerenone) in the EU to treat adults with symptomatic chronic heart failure with LVEF 40% (HFmrEF/HFpEF), expanding beyond its prior use in chronic kidney disease with type 2 diabetes